Sarepta Therapeutics market cap SRPT

Share price times shares outstanding: what the whole company sells for, since 2011.

Sarepta Therapeutics is worth $1.9B at the close on Oct 23, 2026, at $17.73 a share.

That is down 16% over the last year and down 70% over five years.

Its highest close in our data was $15.2B in Jun 2024.

Market cap over time

Year	End of year	Low	High	Change
2026 so far	$1.9B	$1.6B	$2.5B	−19%
2025	$2.3B	$1.2B	$12.1B	−80%
2024	$11.6B	$9.1B	$15.2B	+29%
2023	$9B	$7.3B	$13.9B	−21%
2022	$11.4B	$5.5B	$11.4B	+45%
2021	$7.8B	$5.3B	$8B	−42%
2020	$13.5B	$6.8B	$13.8B	+39%
2019	$9.7B	$5.6B	$11.6B	+34%
2018	$7.2B	$3.5B	$10.7B	+100%
2017	$3.6B	$1.5B	$3.7B	+140%
2016	$1.5B	$537.8M	$2.9B	−14%
2015	$1.7B	$495.7M	$1.7B	+204%
2014	$575M	$545.7M	$1.4B	−23%
2013	$744.1M	$540.1M	$1.8B	+23%
2012	$605.5M	$81.7M	$776M	+495%
2011	$101.8M	$76M	$181.9M	n/a

Companies in Drug Manufacturers - General nearest Sarepta Therapeutics' size, closest first, today.

Company	Market cap
SRPTSarepta Therapeutics	$1.9B
ANIPANI Pharmaceuticals	$1.7B
HRMYHarmony Biosciences	$2.1B
PAHCPhibro Animal Health	$1.6B
PBHPrestige Consumer Healthcare	$2.3B
ANABAnaptysbio	$1.5B
PCRXPacira BioSciences	$1.5B
NRIXNurix Therapeutics	$2.8B
OMEROmeros	$1.2B
AMPHAmphastar Pharmaceuticals	$1.1B
OGNOrganon	$3.6B
Peer median	$1.6B